GB1256404A - 0-oxa-3,8-diazaspiro(4,5)decan-2,4-diones - Google Patents

0-oxa-3,8-diazaspiro(4,5)decan-2,4-diones

Info

Publication number
GB1256404A
GB1256404A GB2836169A GB2836169A GB1256404A GB 1256404 A GB1256404 A GB 1256404A GB 2836169 A GB2836169 A GB 2836169A GB 2836169 A GB2836169 A GB 2836169A GB 1256404 A GB1256404 A GB 1256404A
Authority
GB
United Kingdom
Prior art keywords
halogen
benzyl
june
group iii
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2836169A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of GB1256404A publication Critical patent/GB1256404A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,256,404. 1 - Oxa - 3,8 - diazaspiro[4,5]- decan - 2,4 - dione derivatives. DAINIPPON PHARMACEUTICAL CO. Ltd. 4 June, 1969 [7 June, 1968; 10 June, 1968 (2)], No. 28361/69. Heading C2C. Novel compounds I (including salts thereof) wherein R 1 is H, benzyl, R<SP>1</SP>(CH 2 )n- (R<SP>1</SP> is halogen, hydroxy or optionally halo-substituted benzoyl and n is 2 or 3) a Group III (R<SP>11</SP> is H, halogen, CF 3, alkoxy, NO 2, CN, alkylthio, alkyl, dialkylaminosulphonyl or acetyl and n is 2 or 3) or a Group IV or V (n is 2 or 3) and R 2 is H, optionally hydroxysubstituted-alkyl optionally halo-substitutedphenyl or benzyl, are obtained: (a) by interaction of VI and R<SP>1</SP> 2 NCO followed by hydrolysis of the intermediate VIII so obtained (R<SP>1</SP> 1 has same meaning as R 1 but is not H and R<SP>1</SP> 2 has same meaning as R 2 but is not H or hydroxy-alkyl and can also be benzoyl or alkanoyl); (b) by hydrogenating I in which R 1 is benzyl to afford corresponding I in which R 1 is H; (c) by alkylating I in which R 1 is H or R 2 is H; (d) by converting I in which R 1 is halogen(CH 2 )n- (prepared utilizing halogen- (CH 2 ) n -halogen<SP>1</SP>) into I wherein R 1 is the Group III, IV or V; (e) by reacting I in which R 1 is HO(CH 2 ) n with R 4 COCl [R 4 is the group III less the (CH 2 ) n fragment] and decarboxylating the intermediate R 4 COO(CH 2 ) n -compound so obtained; or (f) by utilizing the Mannich reaction on I in which R i is H (the other reactants are formaldehyde or paraformaldehyde and p-Y-C 6 H 4 -COMe wherein Y is H or halogen) to afford I in which R 1 is p-Y-C 6 H 4 - CO(CH 2 ) 2 -. 1 - Benzyl - 4 - piperidone is obtained by interaction of benzyl isocyanate and 1-benzyl-4- cyano -4-piperidinol. Pharmaceutical preparations useful as psychotropic agents contain I as active ingredient; administration is, e.g. orally or intraperitoneally.
GB2836169A 1968-06-07 1969-06-04 0-oxa-3,8-diazaspiro(4,5)decan-2,4-diones Expired GB1256404A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3902768 1968-06-07
JP3985868 1968-06-10
JP3985768 1968-06-10

Publications (1)

Publication Number Publication Date
GB1256404A true GB1256404A (en) 1971-12-08

Family

ID=27290018

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2836169A Expired GB1256404A (en) 1968-06-07 1969-06-04 0-oxa-3,8-diazaspiro(4,5)decan-2,4-diones

Country Status (6)

Country Link
BE (1) BE734203A (en)
CH (1) CH517111A (en)
DE (1) DE1928704A1 (en)
FR (1) FR2010411B1 (en)
GB (1) GB1256404A (en)
SE (1) SE350051B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111574537A (en) * 2020-05-20 2020-08-25 成都药明康德新药开发有限公司 Synthesis method of tert-butyl-8-oxa-3, 11-diazaspiro [5.6] dodecane-3-formylate

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790675A (en) * 1971-10-29 1973-04-27 Science Union & Cie NEW DERIVATIVES OF OXA-1 DIAZA-3.8 SPIRO (4.5) DECANE
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
FR2691459B1 (en) * 1992-05-25 1995-06-09 Adir NOVEL PHENOTHIAZINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111574537A (en) * 2020-05-20 2020-08-25 成都药明康德新药开发有限公司 Synthesis method of tert-butyl-8-oxa-3, 11-diazaspiro [5.6] dodecane-3-formylate
CN111574537B (en) * 2020-05-20 2022-11-15 成都药明康德新药开发有限公司 Synthesis method of tert-butyl-8-oxa-3,11-diazaspiro [5.6] dodecane-3-formylate

Also Published As

Publication number Publication date
CH517111A (en) 1971-12-31
SE350051B (en) 1972-10-16
DE1928704A1 (en) 1969-12-11
FR2010411A1 (en) 1970-02-13
FR2010411B1 (en) 1973-07-13
BE734203A (en) 1969-11-17

Similar Documents

Publication Publication Date Title
GB1323283A (en) Benzothiazine 1,1, dioxide derivatives
GB1256404A (en) 0-oxa-3,8-diazaspiro(4,5)decan-2,4-diones
GB1154742A (en) Pyrrylamino Ketones
IE40052L (en) Piperidinoalkylindoles
GB1153578A (en) Phenyl-Isopropylamine Derivatives
ES8302653A1 (en) Lysine salts
IE36787L (en) 2, 4, 5-trisubstituted oxazoles.
IE39624L (en) Carbazole derivatives
IE40290L (en) Substituted 3-aminopyrroles
IE44047L (en) Cyanoacetanilide derivatives.
GB1394791A (en) Diphenylalkyllactamimide derivatives
GR3002884T3 (en) Substituted chinoxalyl-imidazolidine-2,4-diones, process for their preparation, their use as medicaments and pharmacological preparations
HUT70047A (en) Process for producing 2-substituted 5-chloroimidazol-4-carbaldehydes
GB1433934A (en) Thioureas
GB1367597A (en) Pyrrolidine derivative
GB1231804A (en)
GB1356991A (en) Kanamycin a salts
ES8705454A1 (en) Imidazoalkylcarboxylic-acid derivatives, process for their preparation and their use in the preparation of pharmaceutically active compounds.
GB1363323A (en) 2 - 2-imidazolyl - pyrimidines and processes for their preparation
IE34348B1 (en) Esters of rho-biphenylylacetic acid
ES8302734A1 (en) Substituted deoxyadenosine derivatives.
ES8105250A1 (en) Substituted decalins, their preparation and use.
IE39639B1 (en) N-substituted cycloserine compounds
ES8605790A1 (en) Process for the preparation of 3,5-disubstituted isoxazoles.
IE35388L (en) Nitrofuryl- and nitrothienyl-amidines